UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas

Journal of clinical oncology, 2012-01, Vol.30 (1), p.78-84

2012

Volltextzugriff (PDF)

Phase 1 trial of autologous dendritic cell vaccination with imiquimod immunomodulation in children and adults with refractory sarcoma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.11542-11542

2021

Volltextzugriff (PDF)

ETCTN/NCI 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for the treatment of unresectable and metastatic conventional chondrosarcoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.11531-11531

2023

Volltextzugriff (PDF)

Large scale multiomic analysis suggests mechanisms of resistance to immunotherapy in leiomyosarcoma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.11512-11512

2021

Volltextzugriff (PDF)

Multiomic analysis to reveal distinct molecular profiles of uterine and nonuterine leiomyosarcoma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.11555-11555

2021

Volltextzugriff (PDF)

Frequency, Characteristics, and Reversibility of Peripheral Neuropathy During Treatment of Advanced Multiple Myeloma With Bortezomib

Journal of clinical oncology, 2006-07, Vol.24 (19), p.3113-3120

2006

Volltextzugriff (PDF)

Come back: Identifying targets to engage young adult survivors who have been lost to follow-up

Journal of clinical oncology, 2018-03, Vol.36 (7_suppl), p.29-29

2018

Volltextzugriff (PDF)

Why are oncologists not testing all NSCLC patients for biomarkers in the U.S. market?

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e21003-e21003

2021

Volltextzugriff (PDF)

Validation of Lysyl Oxidase As a Prognostic Marker for Metastasis and Survival in Head and Neck Squamous Cell Carcinoma: Radiation Therapy Oncology Group Trial 90-03

Journal of clinical oncology, 2009-09, Vol.27 (26), p.4281-4286

2009

Volltextzugriff (PDF)

Genomic profiling of melanomas of unknown primary

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e21048-e21048

2017

Volltextzugriff (PDF)

Identification of somatic mutations and neoantigens to predict development of autoimmune adverse events to immune therapy in melanoma

Journal of clinical oncology, 2017-03, Vol.35 (7_suppl), p.19-19

2017

Volltextzugriff (PDF)

Designing a survivorship and supportive care center at a comprehensive cancer center

Journal of clinical oncology, 2018-03, Vol.36 (7_suppl), p.159-159

2018

Volltextzugriff (PDF)

Identification of somatic mutations to predict development of autoimmune adverse events to immune therapy in melanoma

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.3041-3041

2016

Volltextzugriff (PDF)

Flavopiridol, A Novel Cyclin-Dependent Kinase Inhibitor, in Metastatic Renal Cancer: A University of Chicago Phase II Consortium Study

Journal of clinical oncology, 2000-01, Vol.18 (2), p.371-375

2000

Volltextzugriff (PDF)

Biomarkers to predict immune-related adverse events with checkpoint inhibitors

Journal of clinical oncology, 2019-03, Vol.37 (8_suppl), p.131-131

2019

Volltextzugriff (PDF)

Pegylated Interferon Alfa-2b Treatment for Patients With Solid Tumors: A Phase I/II Study

Journal of clinical oncology, 2002-09, Vol.20 (18), p.3841-3849

2002

Volltextzugriff (PDF)

A germ line polymorphism in the RET proto-oncogene predicts risk and recurrence in desmoplastic melanoma

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.8558-8558

2011

Volltextzugriff (PDF)

Intestinal HIF-2 to protect against radiation-induced gastrointestinal syndrome

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.10629-10629

2012

Volltextzugriff (PDF)

A phase I trial of combined tivozanib (AV-951) and temsirolimus therapy in patients (pts) with renal cell carcinoma (RCC)

Journal of clinical oncology, 2011-03, Vol.29 (7_suppl), p.330-330

2011

Volltextzugriff (PDF)

Results from a phase I trial of tivozanib (AV-951) combined with temsirolimus therapy in patients (pts) with renal cell carcinoma (RCC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.4549-4549

2011

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of LU79553, a DNA Intercalating Bisnaphthalimide, in Patients With Solid Malignancies

Journal of clinical oncology, 2001-02, Vol.19 (3), p.857-869

2001

Volltextzugriff (PDF)

Vinorelbine as first-line chemotherapy for metastatic breast carcinoma

Journal of clinical oncology, 1994-02, Vol.12 (2), p.336-341

1994

Volltextzugriff (PDF)

Population-based analysis of multimodality treatment of gastric cancer

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.124-124

2011

Volltextzugriff (PDF)

Identification of pre- and post-treatment markers of efficacy in patients with renal cancer treated with MVA-5T4 in a phase III study

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.2542-2542

2011

Volltextzugriff (PDF)

Vinorelbine and Paclitaxel as First-Line Chemotherapy in Metastatic Breast Cancer

Journal of clinical oncology, 1999-01, Vol.17 (1), p.74-81

1999

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(53)

Sprache

Englisch
(53)
Japanisch
(4)

Erscheinungsjahr

n.n

Kollektion

EZB Electronic Journals Library
(53)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(53)
NUS Single-Journal Subscriptions
(53)
IngentaConnect Journals
(23)
IngentaConnect
(23)
MEDLINE
(14)

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas

Phase 1 trial of autologous dendritic cell vaccination with imiquimod immunomodulation in children and adults with refractory sarcoma

ETCTN/NCI 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for the treatment of unresectable and metastatic conventional chondrosarcoma

Large scale multiomic analysis suggests mechanisms of resistance to immunotherapy in leiomyosarcoma

Multiomic analysis to reveal distinct molecular profiles of uterine and nonuterine leiomyosarcoma

Frequency, Characteristics, and Reversibility of Peripheral Neuropathy During Treatment of Advanced Multiple Myeloma With Bortezomib

Come back: Identifying targets to engage young adult survivors who have been lost to follow-up

Why are oncologists not testing all NSCLC patients for biomarkers in the U.S. market?

Validation of Lysyl Oxidase As a Prognostic Marker for Metastasis and Survival in Head and Neck Squamous Cell Carcinoma: Radiation Therapy Oncology Group Trial 90-03

Genomic profiling of melanomas of unknown primary

Identification of somatic mutations and neoantigens to predict development of autoimmune adverse events to immune therapy in melanoma

Designing a survivorship and supportive care center at a comprehensive cancer center

Identification of somatic mutations to predict development of autoimmune adverse events to immune therapy in melanoma

Flavopiridol, A Novel Cyclin-Dependent Kinase Inhibitor, in Metastatic Renal Cancer: A University of Chicago Phase II Consortium Study

Biomarkers to predict immune-related adverse events with checkpoint inhibitors

Pegylated Interferon Alfa-2b Treatment for Patients With Solid Tumors: A Phase I/II Study

A germ line polymorphism in the RET proto-oncogene predicts risk and recurrence in desmoplastic melanoma

Intestinal HIF-2 to protect against radiation-induced gastrointestinal syndrome

A phase I trial of combined tivozanib (AV-951) and temsirolimus therapy in patients (pts) with renal cell carcinoma (RCC)

Results from a phase I trial of tivozanib (AV-951) combined with temsirolimus therapy in patients (pts) with renal cell carcinoma (RCC)

Phase I and Pharmacokinetic Study of LU79553, a DNA Intercalating Bisnaphthalimide, in Patients With Solid Malignancies

Vinorelbine as first-line chemotherapy for metastatic breast carcinoma

Population-based analysis of multimodality treatment of gastric cancer

Identification of pre- and post-treatment markers of efficacy in patients with renal cancer treated with MVA-5T4 in a phase III study

Vinorelbine and Paclitaxel as First-Line Chemotherapy in Metastatic Breast Cancer

Aktive Filter

Suchergebnisse filtern